Back
Grupo Financiero Banorte SAB de CV Vs. ANI Pharmaceuticals Industry Stock Comparison
Sell
33
GBOOY
Grupo Financiero Banorte SAB de CV
Last Price:
35.40
Seasonality Move:
3.03%
Sell
46
ANIP
ANI Pharmaceuticals
Last Price:
61.01
Seasonality Move:
5.08%
Sell
33
Grupo Financiero Banorte SAB de CV (GBOOY)
is a Sell
Is Grupo Financiero Banorte SAB de CV a Buy, Sell or Hold?
- The current Grupo Financiero Banorte SAB de CV [GBOOY] share price is $35.80. The Score for GBOOY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- GBOOY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.85. The Score for ANIP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- ANIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GBOOY Stock Price Chart
What is Grupo Financiero Banorte SAB de CV's stock price today?
-
The Grupo Financiero Banorte SAB de CV share price today is $35.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GBOOY is experiencing slight buying pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
GBOOY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 47.86 | Sell |
Chaikin Money Flow: | 1103 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.05 - 38.13) | Sell |
Bollinger Bands (100): | (34.92 - 40.06) | Sell |
ANIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 60.98 | Buy |
Chaikin Money Flow: | 213168 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.73 - 59.99) | Buy |
Bollinger Bands (100): | (57.71 - 62.95) | Buy |
GBOOY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.94 | Sell |
20-day SMA: | 36.01 | Sell |
50-day SMA: | 36.25 | Sell |
200-day SMA: | 43.92 | Sell |
8-day EMA: | 36.07 | Sell |
20-day EMA: | 36.14 | Sell |
50-day EMA: | 36.62 | Sell |
200-day EMA: | 40.89 | Sell |
ANIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.64 | Buy |
20-day SMA: | 58.88 | Buy |
50-day SMA: | 58.7 | Buy |
200-day SMA: | 62.08 | Sell |
8-day EMA: | 59.48 | Buy |
20-day EMA: | 58.83 | Buy |
50-day EMA: | 59.09 | Buy |
200-day EMA: | 59.9 | Buy |
Grupo Financiero Banorte SAB de CV Earnings Growth & GBOOY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.51 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.49 per share.
Grupo Financiero Banorte SAB de CV Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ANI Pharmaceuticals Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |